|Articles|July 1, 2022
News Roundup: June 27 to July 1
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Pharmacies Limiting Plan B Purchases After Roe v. Wade Reversal
The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.
Before Getting Better, the Opioid Crisis Will Get Worse
500,000 lives expected to be lost to opioids over the next 10 years
Legislation Introduced to Cut Delays for Bringing Safe Eye Drops to Market
The CLEAR Act would clarify the FDA’s authority to regulate products, including eye drops, after a court decision created unnecessary confusion and turmoil.
Supreme Court Issues Ruling on Opioid Prescriptions
Ruling comes in cases with prison sentences for convictions over prescription drugs.
Handling Headache: Types, Treatments, and Counseling Pearls
Understanding headaches and their various treatment options can help pharmacists counsel patients at the counter.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
2
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
3
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
4
Pharmacists as the Front Line of Vaccine Education and Access
5
